Key facts
- This page summarizes Marc A. Cohen's Form 4 filing for Frequency Therapeutics, Inc. (KRRO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 Jun 2022, 16:19.
Marc A. Cohen - 21 Jun 2022 Form 4 Insider Report for Frequency Therapeutics, Inc. (KRRO)
- Reporting relationship
- Director
- Issuer ticker
- KRRO
- Reported as of
- 21 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Jun 2022, 16:19:07 UTC
- Prior SEC filing
- 18 Jan 2022
- Next SEC filing
- 23 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ James P. Abely, Attorney-in-Fact for Marc A. Cohen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Marc A. Cohen filed Form 4 for Frequency Therapeutics, Inc. (KRRO) on 23 Jun 2022.
Change
- Previous filing in this sequence was filed on 18 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FREQ
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +14,846
- Change %
- Price
- $0.000000
- Shares after
- 14,846
- Date
- 21 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 14,846
- Exercise price
- $1.17
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option vests in full on the earlier of June 21, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders.